Advertisement
KALA vs PALI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KALA is a Hold and PALI is a Hold.
KALA sees MACD Histogram crosses below signal line
KALA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 02, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 37 instances where the indicator turned negative. In 36 of the 37 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 24, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KALA as a result. In 65 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KALA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for KALA entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +11.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where KALA advanced for three days, in 167 of 208 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
KALA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.963) is normal, around the industry mean (26.782). P/E Ratio (11.062) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (437.542).
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. KALA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KALA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
PALI's RSI Oscillator climbs out of oversold territory
The RSI Indicator for PALI moved out of oversold territory on October 01, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 40 similar instances when the indicator left oversold territory. In 37 of the 40 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on PALI as a result. In 83 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.
The Moving Average Convergence Divergence (MACD) for PALI just turned positive on October 08, 2026. Looking at past instances where PALI's MACD turned positive, the stock continued to rise in 33 of 42 cases over the following month. The odds of a continued upward trend are 79%.
Following a +5.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where PALI advanced for three days, in 168 of 199 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
PALI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 34 of 38 cases where PALI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 89%.
PALI moved below its 50-day moving average on September 15, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for PALI crossed bearishly below the 50-day moving average on September 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PALI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for PALI entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.147) is normal, around the industry mean (26.782). P/E Ratio (2.305) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (526.316) is also within normal values, averaging (437.542).
The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. PALI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PALI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
KALA | PALI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 52 | 4 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 64 Fair valued | 63 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 98 | |
PRICE GROWTH RATING 1..100 | 98 | 84 | |
P/E GROWTH RATING 1..100 | 97 | 99 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PALI's Valuation (63) in the null industry is in the same range as KALA (64) in the Pharmaceuticals Major industry. This means that PALI’s stock grew similarly to KALA’s over the last 12 months.
PALI's Profit vs Risk Rating (100) in the null industry is in the same range as KALA (100) in the Pharmaceuticals Major industry. This means that PALI’s stock grew similarly to KALA’s over the last 12 months.
PALI's SMR Rating (98) in the null industry is in the same range as KALA (100) in the Pharmaceuticals Major industry. This means that PALI’s stock grew similarly to KALA’s over the last 12 months.
PALI's Price Growth Rating (84) in the null industry is in the same range as KALA (98) in the Pharmaceuticals Major industry. This means that PALI’s stock grew similarly to KALA’s over the last 12 months.
KALA's P/E Growth Rating (97) in the Pharmaceuticals Major industry is in the same range as PALI (99) in the null industry. This means that KALA’s stock grew similarly to PALI’s over the last 12 months.
| KALA | PALI | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 88% | 1 day ago 89% |
| Momentum ODDS (%) | 1 day ago 88% | 1 day ago 87% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 79% |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 85% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Advances ODDS (%) | 25 days ago 80% | 1 day ago 84% |
| Declines ODDS (%) | 3 days ago 90% | 9 days ago 90% |
| BollingerBands ODDS (%) | 1 day ago 74% | 1 day ago 77% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
KALA’s FA Score shows that 0 FA rating(s) are green while PALI’s FA Score has 0 green FA rating(s).
- KALA’s FA Score: 0 green, 5 red.
- PALI’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
KALA’s TA Score shows that 4 TA indicator(s) are bullish while PALI’s TA Score has 5 bullish TA indicator(s).
- KALA’s TA Score: 4 bullish, 4 bearish.
- PALI’s TA Score: 5 bullish, 5 bearish.
Price Growth
KALA (@Biotechnology) experienced а -34.25% price change this week, while PALI (@Biotechnology) price change was +6.21% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -7.32%. For the same industry, the average monthly price growth was -15.10%, and the average quarterly price growth was -18.48%.
Reported Earning Dates
PALI is expected to report earnings on Nov 16, 2026.
Industries' Descriptions
@Biotechnology (-7.32% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VCLT | 69.97 | 0.91 | +1.32% |
| Vanguard Long-Term Corporate Bond ETF (VCLT) | |||
| ADIV | 19.59 | 0.23 | +1.19% |
| Guinness Atkinson Asia Pacific Dividend Builder ETF (ADIV) | |||
| ENHU | 28.80 | 0.13 | +0.44% |
| iShares Enhanced Large Cap Core Active ETF (ENHU) | |||
| SDFI | 34.88 | 0.07 | +0.20% |
| AB Short Duration Income ETF (SDFI) | |||
| RSPG | 115.90 | -1.83 | -1.55% |
| Invesco S&P 500 Equal Weight Energy ETF (RSPG) | |||
KALA and
Correlation & Price change
A.I.dvisor indicates that over the last year, KALA has been closely correlated with MLTX. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if KALA jumps, then MLTX could also see price increases.
| Ticker / NAME | Correlation To KALA | 1D Price Change % | ||
|---|---|---|---|---|
| KALA | 100% | +3.72% | ||
| MLTX - KALA | 82% Closely correlated | +1.18% | ||
| LRMR - KALA | 38% Loosely correlated | -4.78% | ||
| CLRB - KALA | 34% Loosely correlated | +0.85% | ||
| PALI - KALA | 31% Poorly correlated | +4.05% | ||
| OVID - KALA | 29% Poorly correlated | +3.20% | ||
More | ||||
PALI and
Correlation & Price change
A.I.dvisor indicates that over the last year, PALI has been closely correlated with RNAC. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if PALI jumps, then RNAC could also see price increases.
| Ticker / NAME | Correlation To PALI | 1D Price Change % | ||
|---|---|---|---|---|
| PALI | 100% | +4.05% | ||
| RNAC - PALI | 81% Closely correlated | +3.79% | ||
| AGEN - PALI | 81% Closely correlated | +2.77% | ||
| NCNA - PALI | 81% Closely correlated | -2.86% | ||
| TAOX - PALI | 81% Closely correlated | +3.57% | ||
| NRXP - PALI | 74% Closely correlated | +4.63% | ||
More | ||||